Latest vaccine candidate News

New data supports effective delivery of DNA-based vaccines using patch
WHO and partners enable access to candidate vaccine and treatments for outbreak of Sudan Ebola virus disease in Uganda
New EU Consortium To Tackle Marburg Virus
UQ and Vaxxas win prize to advance patch-based mRNA COVID-19 vaccine
Australia’s first mRNA vaccine candidate could address COVID ‘immune imprinting’
Governor of Queensland visit to Institute for Biomedicine and Glycomics highlights innovative malaria vaccine research
Volunteers needed for trial of newly developed vaccine candidate for respiratory diseases
Monash scientists uncover new, potentially longer lasting, covid vaccine targets
Types of data requested to inform December 2024 COVID-19 vaccine antigen composition deliberations
TB vaccine candidates to progress to second round of tournament
Game-changing Needle-free Covid Intranasal Vaccine
Personalised cancer vaccines to be produced at new UQ lab
New initiative launched to advance mRNA vaccine development against human avian influenza (H5N1)
Personalised cancer vaccines to be produced at new UQ lab
Vaccines to treat human papillomavirus could be a significant innovation in the fight against cervical cancer
Ticking Boxes To Defeat Deadly Parasite
A promising vaccine approach to induce longer-lasting protective immunity against COVID-19
UQ secures global partnership to create homegrown lifesaving vaccines
University of Queensland partners with Georgia’s Emory University to establish Queensland Emory Vaccine Centre
Insights from patient who cleared hepatitis C could lead to vaccine
Acquisition of Icosavax Completed
Vaccine shows promise against CMV, a virus that causes birth defects
AstraZeneca to acquire Icosavax, including potential first-in-class RSV and hMPV combination vaccine with positive Phase II data
BioNTech to establish clinical-scale mRNA manufacturing facility at La Trobe University
Successful clinical trial for re-engineered UQ vaccine
Australia, US scientists team up on African swine fever vaccine
World-first human challenge trial to test efficacy of Strep A and rheumatic heart disease vaccine
Innovative biopolymer particle-based platform technology to develop vaccine candidates
National team to advance innovative biopolymer particle-based platform technology
Early career researchers awarded $5.1m funding
Vaxxas awarded Wellcome grant for needle-free typhoid vaccine patch study
Australian vaccine breakthrough offers hope against EBV-associated cancers and MS
Vaccine breakthrough offers hope against EBV-associated cancers and MS
Moderna submits RSV vaccine to global regulatory agencies
Organoids shown to speed glycoengineered vaccine development
SAGE updates COVID-19 vaccination guidance
Volunteers needed for ‘Clamp2’ vaccine testing
Victoria to skill-up Asia Pacific’s future mRNA medicines manufacturing workforce
Industry collaborations progress research in advanced imaging and vaccination
Preventing costly cattle disease to boost fertility rates
Griffith unlocking secrets to Strep virulence
WHO: Invest in New TB Vaccines for Health, Economic Gains
Experimental vaccines offer long-term protection against severe COVID
Honourable Anna Bligh AC joins forces with Griffith University to fight malaria
Phase 2 trial of ChulaCov19 BNA159 mRNA Vaccine to start in Australia
Researchers find Strep A’s Achilles heel with potential vaccine to prevent rheumatic heart disease
CSL Enters Licensing Agreement
Burnet welcomes grant for mRNA vaccine development